SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,331.90 |
| Enterprise Value ($M) | 2,972.88 |
| Book Value ($M) | 191.06 |
| Book Value / Share | 1.54 |
| Price / Book | 12.20 |
| NCAV ($M) | -253.27 |
| NCAV / Share | -2.04 |
| Price / NCAV | -9.21 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.57 |
| Return on Assets (ROA) | -0.96 |
| Return on Equity (ROE) | -3.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.74 |
| Current Ratio | 6.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 695.47 |
| Assets | 1,139.80 |
| Liabilities | 948.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3.55 |
| Operating Income | -601.08 |
| Net Income | -599.49 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -462.85 |
| Cash from Investing | -420.07 |
| Cash from Financing | 870.52 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Avoro Capital Advisors LLC | 7.20 | ||
| 13G/A | State Street Corp | 5.10 | -6.90 | |
| 13G/A | Vanguard Group Inc | 10.01 | 16.23 | |
| 13G/A | BlackRock, Inc. | 12.40 | 4.66 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 218,749 | 867,889 | 25.20 | |
| 362,137 | 1,407,662 | 25.73 | |
| 208,761 | 946,892 | 22.05 | |
| 205,774 | 1,138,579 | 18.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APLS – Apellis Pharmaceuticals, Inc. | ARQT – Arcutis Biotherapeutics, Inc. |
| ARVN – Arvinas, Inc. | ASMB – Assembly Biosciences, Inc. |
| ATHA – Athira Pharma, Inc. |